SCHEMBL18714404

SCHEMBL18714404

CC[C@@H](C)NC(=O)C1CCOCC1

nearest known ligand 0.65

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.65
GAA P10253 3/20 0.56
ALDH1A1 P00352 4/20 0.49
KDM4E B2RXH2 1/20 0.48
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
EPHX1 P07099 1/20 0.44
ACACB O00763 1/20 0.43
HSD17B10 Q99714 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HTT P42858 2/20 0.41
LMNA P02545 1/20 0.39
MMP1 P03956 1/20 0.39
MMP2 P08253 1/20 0.39
MMP3 P08254 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14241975 0.87 GAA (0.65) SMN1; SMN2GAAALDH1A1KDM4ECYP2C9
SCHEMBL23480154 0.87 GAA (0.65) SMN1; SMN2GAAALDH1A1KDM4ECYP2C9
SCHEMBL9558762 0.84 SMN1; SMN2 (0.49) SMN1; SMN2GAAALDH1A1KDM4EACACB
SCHEMBL9558751 0.84 SMN1; SMN2 (0.49) SMN1; SMN2GAAALDH1A1KDM4EACACB
SCHEMBL10308293 0.81 GAA (0.61) SMN1; SMN2GAAALDH1A1KDM4ECYP2C9
SCHEMBL24567736 0.81 GAA (0.61) SMN1; SMN2GAAALDH1A1KDM4ECYP2C9
SCHEMBL18714403 0.81 SMN1; SMN2 (0.47) SMN1; SMN2GAAALDH1A1ACACBL3MBTL1
SCHEMBL12448285 0.81 SMN1; SMN2 (0.51) SMN1; SMN2GAAHTTLMNA
SCHEMBL3634427 0.80 SMN1; SMN2 (0.46) SMN1; SMN2GAAACACBL3MBTL1HTT
SCHEMBL15199110 0.80 GAA (0.58) SMN1; SMN2GAAALDH1A1KDM4ECYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9610284-B2 4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2H-pyran-4-yl)-1H-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor GLAXOSMITHKLINE LLC (US) 2017-04-04 US disclosed